Gp120 sequence variation in brain and in T-lymphocyte human immunodeficiency virus type 1 primary isolates

Journal of Human Virology

Volumn 1, Issue 1, 1997, Pages 3-18

  Gartner, Suzanne ^a,b,e   McDonald, Richard A ^b   Hunter, Edward A ^a   Bouwman, Femke ^a,d   Liu, Yiling ^a   Popovic, Mikulas ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Brain; gp120; HIV 1 genetic variation; V4

Indexed keywords

GLYCOPROTEIN GP 120;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BRAIN; CLASSIFICATION; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NEWBORN; PHYLOGENY; SEQUENCE HOMOLOGY; T LYMPHOCYTE; VIROLOGY;

ADULT; AMINO ACID SEQUENCE; BRAIN; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES; VARIATION (GENETICS);

EID: 0031261172     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Price RW. Neurological complications of HIV infection. Lancet 1996;348:445-452.
2. Lipton SA. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol 1996;6:507-517.
3. Masliah E, Ge N, Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit Rev Neurobiol 1996;10: 57-67.
4. Glass JD, Johnson RT. Human immunodeficiency virus and the brain. Annu Rev Neurosci 1996;19:1-26.
5. Gelbard HA, Epstein LG. HIV-1 encephalopathy in children. Curr Opin Pediatr 1995;7;655-662.
6. Yoshida M, Bradley WG, Shapshak P, et al. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv Neuroimmunol 1995;5:335-338.
7. Johnson RT. The pathogenesis of HIV infections of the brain. Curr Top Microbiol Immunol 1995;202:3-10
8. Nottet HS, Gendelman HE. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today 1995;16:441-448.
9. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology 1993;43:2245-2252.
10. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517-524.
11. Price RW, Brew BJ, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-591.
12. Tyor WR, Becker PS, Griffin JW, et al. Cytokine expression in the brain during AIDS. Ann Neurol 1992;31:349-360.
13. Grimaldi LME, Martino GV, Franciotta DM, et al. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 1991;29:21-25.
14. Mintz M, Rapaport R, Oleske JM, Connor EM, Koenigsberger MR. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 1989;143:771-74.
15. Wahl SM, Allen JB, McCartney-Francis N, et al. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991; 173:981-991.
16. Genis P, Jett M, Bernton EW, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176:1703-1718.
17. Gelbard HA, Nottet HSLM, Swindells S, et al. Platelet activating factor: a candidate immunodeficiency virus type 1-induced neurotoxin. J Virol 1994;68:4628-4635.
18. Dawson VL, Dawson TM, Uhl GR, Snyder SH. Human immunodeficiency virus type 1 core protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci U S A 1993;90:3256-3259.
19. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996;274:1917-1921.
20. Heyes MP, Brew BJ, Martin A, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 1991;29:202-209.
21. Power C, McArthur JC, Johnson RT, et al. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994;68:4643-4649.
22. Kuiken CL, Goudsmit J, Weiller GF, et al. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J Gen Virol 1995;76:173-180.
23. Di Stefano M, Wilt S, Gray F, Dubois-Dalcq M, Chiodi F. HIV type 1 V3 sequences and the development of dementia during AIDS. AIDS Res Hum Retroviruses 1996; 12:471-476.
24. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, Goudsmit J. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 1991;180:583-590.
25. Keys B, Karis J, Fadeel B, et al. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 1993;196:475-483.
26. Korber BTM, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994;68:7467-7481.
27. Reddy RT, Achim CL, Sirko DA, et al. and the HIV Neurobehavioral Research Group. Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Res Hum Retroviruses 1996;12:477-482.
28. Liu ZQ, Wood C, Levy JA, Cheng-Mayer C. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. J Virol 1990;64:6148-6153.
29. Haggerty S, Stevenson M. Predominance of distinct viral genotypes in brain and lymph node compartments of HIV-1-infected individuals. Viral Immunol 1991;4:123-131.
30. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly form uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol 1991;65:3973-3985.
31. Monken CE, Wu B, Srinivasan A. High resolution analysis of HIV-1 quasispecies in the brain. AIDS 1995;9:345-349.
32. Pang S, Vinters HV, Akashi T, O'Brien WA, Chen ISY. HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J AIDS 1991;4: 1082-1092.
33. Hughes ES, Bell JE, Simmonds P. Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17 (gag) and env genes. J Virol 1997;71:1272-1280.
34. Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M. Virus Isolation from and identification of HTLV-III/ LAV-producing cells in brain tissue from an AIDS patient. JAMA 1986;256:2365-2371.
35. Gartner S, Popovic M. Virus isolation and production. In: Aldovini A, Walker B, editors. Techniques in HIV research. New York, NY: Stockton Press, 1990:53-70.
36. Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, Wong-Staal F. Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature 1984; 312:166-169.
37. Gartner S, Popovic M. Macrophage tropism of HIV-1. AIDS Res Hum Retroviruses 1990;6:1017-1021.
38. Innocenti P, Ottmann M, Morand P, Leclercq P, Seigneurin J. HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res Hum Retroviruses 1992;8:261-268.
39. Modrow S, Hahn BH, Shaw GM, Gallo RC, Wong-Staal F, Wolf H. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol 1987;61:570-578.
40. Wolinsky SM, Wike CM, Korber BTM, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255:1134-1137.
41. Wike CM, Korber BT, Daniels MR, et al. HIV-1 sequence variation between isolates from mother-infant transmission pairs. AIDS Res Hum Retroviruses 1992;8:1297-300.
42. Meyerhans A, Cheynier R, Alben J, et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989;58:901-910.
43. Ivanoff LA, Dubay JW, Morris JF, et al. V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology 1992;187:423-432.
44. Groenink M, Fouchier RAM, Broersen S, et al. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 1993;260:1513-1516.
45. Fox DG, Balfe P, Palmer CP, May JC, Arnold C, McKeating JA. Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site. J Virol 1997;71:759-765.
46. Toohey K, Wehrly K, Nishio J, Ferryman S, Chesebro B. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 1995;213:70-79.
47. Shioda T, Levy JA, Cheng-Mayer C. Macrophage and T-cell line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991;349: 167-169.
48. Wolinsky SM, Korber BTM, Neumann AU, et al. Adaptive evolution of human immunodeficiency virus type 1 during the natural course of infection. Science 1996;272:537-542.
49. Pang S, Shlesinger Y, Daar ES, Moudgil T, Ho D, Chen IS. Rapid generation of sequence variation during primary HIV-1 infection. AIDS 1992;6:453-460.
50. Overbaugh J, Rudensey LM, Papenhausen MD, Benveniste RE, Morton WR. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J Virol 1991;65:7025-7031.
51. McDonald RA, Mayers DL, Chung RC, Wagner KF, Ratto-Kim S, Birx DL, Michael NL. Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function. J Virol 1997;71:1871-1879.
52. Overbaugh J, Rudensey LM. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques. J Virol 1992;66:5937-5948.
53. Kinsey NE, Anderson MG, Unangst TJ, et al. Antigenic variation of SIV: mutations in V4 alter the neutralization profile. Virology 1996;221:14-21.
54. Cichutek K, Merget H, Norley S, et al. Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc Natl Acad Sci U S A 1992;89:7365-7369-
55. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJS, Richman DD. In vivo compartmentalization of human immunodeficiency virus-evidence from the examination of pol sequences from autopsy tissues. J Virol 1997; 71:2059-2071.
56. Berson JF, Long D, Boranz BJ, Rucker J, Jirik FR, Doms RW. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol 1996;70:6288-6295.
57. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.